Revisiting the role of ABC transporters in multidrug-resistant cancer
2018 · Nature reviews. Cancer · 1,767 citations
https://doi.org/10.1038/s41568-018-0005-8
M
Michael M. Gottesman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
4.6K
Citations
14
h-index
15
i10-index
Michael M. Gottesman is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Drug Transport and Resistance Mechanisms & HIV/AIDS drug development and treatment & RNA Interference and Gene Delivery. The author has an h-index of 14, co-authored 15 publications.
Papers by this author
worksMechanisms of Multidrug Resistance in Cancer
2009 · Methods in molecular biology · 678 citations
https://doi.org/10.1007/978-1-60761-416-6_4
The Inhibitor Ko143 Is Not Specific for ABCG2
2015 · Journal of Pharmacology and Experimental Therapeutics · 135 citations
https://doi.org/10.1124/jpet.115.225482
Collateral Sensitivity of Multidrug-Resistant Cells to the Orphan Drug Tiopronin
2011 · Journal of Medicinal Chemistry · 37 citations
https://doi.org/10.1021/jm2001663
Multidrug transporters: recent insights from cryo-electron microscopy-derived atomic structures and animal models
2020 · F1000Research · 30 citations
https://doi.org/10.12688/f1000research.21295.1
Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms
2020 · Translational Oncology · 16 citations
https://doi.org/10.1016/j.tranon.2020.100917
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat